FDA Grants Emergency Use Authorization for Home Collection Kit for Advanta Dx SARS-CoV-2 RT-PCR Assay
March 01, 2021 08:30 ET | Source: Fluidigm Corporation Fluidigm Corporation
Collaboration Agreement to Market
Online
AZOVA Digital Health Platform Provides Patient Questionnaire, Process for Prescription, Kit Purchase, Sample Collection, and Secure Delivery of Test Results
SOUTH SAN FRANCISCO, Calif., March 01, 2021 (GLOBE NEWSWIRE) Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the AZOVA™ COVID-19 Test Collection Kit for use with the Fluidigm® Advanta™ Dx SARS-CoV-2 RT-PCR Assay on the company’s Biomark™ HD platform.
University of Southampton publish their Equal Pay Review
By consulting with Trade Unions and staff networks, the University has reviewed the data in their aim to provide equal pay with respect to gender.
The Equal Pay Review, in partnership with the government requirement to publish Gender Pay Gap data (under the Gender Pay Gap Service), will help analyse the pay gap.
The 2019 Equal Pay Review displays that the University of Southampton continues to provide equal pay, specifically in regards to work of equal value with respect to gender. Further conclusions about the intersection of ethnicity and disability cannot be asserted, but it is suggested.
Share:
SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research and development experience in academic, government,
in vitro diagnostic and device industry settings.
Dr. Stankovic is currently managing partner at Koliada Consulting, LLC, a firm focused on biotech, medical devices and
in vitro diagnostics. Previously, she was Senior Vice President, World Wide Regional Medical Affairs and Global Health, for Becton, Dickinson and Company (BD). Dr. Stankovic served in senior roles at BD for more than a decade, leading medical affairs and clinical operations for various BD business units.